Back to Search
Start Over
COVID-19 in Cladribine-treated patient with multiple sclerosis.
- Source :
-
Journal of neuroimmunology [J Neuroimmunol] 2021 Oct 15; Vol. 359, pp. 577690. Date of Electronic Publication: 2021 Aug 08. - Publication Year :
- 2021
-
Abstract
- Case report describing a patient infected with COVID-19 after initiation of Cladribine, with a favorable disease course and positive seroconversion.<br /> (Copyright © 2021. Published by Elsevier B.V.)
- Subjects :
- COVID-19 diagnostic imaging
Cladribine pharmacology
Drug Administration Schedule
Humans
Immunity, Humoral physiology
Immunosuppressive Agents pharmacology
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting diagnostic imaging
Treatment Outcome
COVID-19 immunology
Cladribine therapeutic use
Immunity, Humoral drug effects
Immunosuppressive Agents therapeutic use
Multiple Sclerosis, Relapsing-Remitting drug therapy
Multiple Sclerosis, Relapsing-Remitting immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1872-8421
- Volume :
- 359
- Database :
- MEDLINE
- Journal :
- Journal of neuroimmunology
- Publication Type :
- Academic Journal
- Accession number :
- 34390951
- Full Text :
- https://doi.org/10.1016/j.jneuroim.2021.577690